Literature DB >> 26810710

A novel library of saccharin and acesulfame derivatives as potent and selective inhibitors of carbonic anhydrase IX and XII isoforms.

Simone Carradori1, Daniela Secci2, Celeste De Monte3, Adriano Mollica1, Mariangela Ceruso4, Atilla Akdemir5, Anatoly P Sobolev6, Rossella Codispoti3, Federica De Cosmi3, Paolo Guglielmi3, Claudiu T Supuran7.   

Abstract

Small libraries of N-substituted saccharin and N-/O-substituted acesulfame derivatives were synthesized and tested as atypical and selective inhibitors of four different isoforms of human carbonic anhydrase (hCA I, II, IX and XII, EC 4.2.1.1). Most of them inhibited hCA XII in the low nanomolar range, hCA IX with KIs ranging between 19 and 2482nM, whereas they were poorly active against hCA II (KIs >10μM) and hCA I (KIs ranging between 318nM and 50μM). Since hCA I and II are ubiquitous off-target isoforms, whereas the cancer-related isoforms hCA IX and XII were recently validated as drug targets, these results represent an encouraging achievement in the development of new anticancer candidates. Moreover, the lack of a classical zinc binding group in the structure of these inhibitors opens innovative, yet unexplored scenarios for different mechanisms of inhibition that could explain the high inhibitory selectivity. A computational approach has been carried out to further rationalize the biological data and to characterize the binding mode of some of these inhibitors.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Acesulfame; Cancer-related isoforms; Carbonic anhydrase inhibitor; N/O-substitution; Saccharin

Mesh:

Substances:

Year:  2016        PMID: 26810710     DOI: 10.1016/j.bmc.2016.01.038

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  13 in total

1.  Advances in Anti-Cancer Drug Development Targeting Carbonic Anhydrase IX and XII.

Authors:  Mam Y Mboge; Robert McKenna; Susan C Frost
Journal:  Top Anticancer Res       Date:  2015

Review 2.  Biophysical, Biochemical, and Cell Based Approaches Used to Decipher the Role of Carbonic Anhydrases in Cancer and to Evaluate the Potency of Targeted Inhibitors.

Authors:  Mam Y Mboge; Anusha Kota; Robert McKenna; Susan C Frost
Journal:  Int J Med Chem       Date:  2018-07-16

3.  Synthesis of Novel Saccharin Derivatives.

Authors:  Gregory M Rankin; Sally-Ann Poulsen
Journal:  Molecules       Date:  2017-03-23       Impact factor: 4.411

4.  Design, Synthesis, Molecular Docking Analysis, and Carbonic Anhydrase IX Inhibitory Evaluations of Novel N-Substituted-β-d-Glucosamine Derivatives that Incorporate Benzenesulfonamides.

Authors:  Feng-Ran Li; Zhan-Fang Fan; Su-Jiao Qi; Yan-Shi Wang; Jian Wang; Yang Liu; Mao-Sheng Cheng
Journal:  Molecules       Date:  2017-05-12       Impact factor: 4.411

5.  Inhibition studies on a panel of human carbonic anhydrases with N1-substituted secondary sulfonamides incorporating thiazolinone or imidazolone-indole tails.

Authors:  Fadi M Awadallah; Silvia Bua; Walaa R Mahmoud; Hossam H Nada; Alessio Nocentini; Claudiu T Supuran
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051

6.  Open saccharin-based secondary sulfonamides as potent and selective inhibitors of cancer-related carbonic anhydrase IX and XII isoforms.

Authors:  Melissa D'Ascenzio; Paolo Guglielmi; Simone Carradori; Daniela Secci; Rosalba Florio; Adriano Mollica; Mariangela Ceruso; Atilla Akdemir; Anatoly P Sobolev; Claudiu T Supuran
Journal:  J Enzyme Inhib Med Chem       Date:  2016-10-26       Impact factor: 5.051

7.  Design, synthesis and biological activity of selective hCAs inhibitors based on 2-(benzylsulfinyl)benzoic acid scaffold.

Authors:  Giulia Rotondi; Paolo Guglielmi; Simone Carradori; Daniela Secci; Celeste De Monte; Barbara De Filippis; Cristina Maccallini; Rosa Amoroso; Roberto Cirilli; Atilla Akdemir; Andrea Angeli; Claudiu T Supuran
Journal:  J Enzyme Inhib Med Chem       Date:  2019-12       Impact factor: 5.051

8.  Discovery of novel 1,3-diaryltriazene sulfonamides as carbonic anhydrase I, II, VII, and IX inhibitors.

Authors:  Suleyman Akocak; Nabih Lolak; Silvia Bua; Claudiu T Supuran
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051

9.  Phaeodactylum tricornutum as a model organism for testing the membrane penetrability of sulphonamide carbonic anhydrase inhibitors.

Authors:  Alessandra Rogato; Sonia Del Prete; Alessio Nocentini; Vincenzo Carginale; Claudiu T Supuran; Clemente Capasso
Journal:  J Enzyme Inhib Med Chem       Date:  2019-12       Impact factor: 5.051

10.  Novel insights on saccharin- and acesulfame-based carbonic anhydrase inhibitors: design, synthesis, modelling investigations and biological activity evaluation.

Authors:  Paolo Guglielmi; Giulia Rotondi; Daniela Secci; Andrea Angeli; Paola Chimenti; Alessio Nocentini; Alessandro Bonardi; Paola Gratteri; Simone Carradori; Claudiu T Supuran
Journal:  J Enzyme Inhib Med Chem       Date:  2020-12       Impact factor: 5.051

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.